Ubs Group Ag Trillium Therapeutics Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Shares
20 transactions
About Trillium Therapeutics Inc.
- Ticker TRIL
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,995,000
- Market Cap $1.94B